Bupropion Impurity 18 | CAS 1623052-09-4 - Request Quote
Bupropion Impurity 18
| SZ CAT No: | SZ-B001062 |
| CAS No | 1623052-09-4 |
| Mol.F. | C13H16ClNO |
| Mol.Wt. | 237.7 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
CHNS Ratio (%) :
Usage Note:
Bupropion Impurity 18 is chemically 6-(3-Chlorophenyl)-3,3,5-trimethyl-3,4-dihydro-2H-1,4-oxazine. Bupropion Impurity 18 is supplied with detailed characterization data compliant with regulatory guideline. Bupropion Impurity 18 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Bupropion.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1623052-09-4
Purchase 1623052-09-4
Order 1623052-09-4
Enquire 1623052-09-4
price of 1623052-09-4
1623052-09-4 Supplier
1623052-09-4 Manufacturer
1623052-09-4 Exporter
buy high quality Bupropion Impurity 18
Purchase Bupropion Impurity 18
Bupropion Impurity 18 suppliers
Bupropion Impurity 18 manufacturers
Bupropion Impurity 18 price
Order Bupropion Impurity 18
Enquire Bupropion Impurity 18
Bupropion Impurity 18 cost
Bupropion Impurity 18 Supplier
Bupropion Impurity 18 Distributor
Bupropion Impurity 18 for Method Validation
Bupropion Reference Standard
Bupropion Impurity 18 for ANDA Filing
Bupropion Impurity 18 for Forced Degradation Studies
Bupropion Impurity 18 Identification Standards
Bupropion Impurity 18 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.